Target intelligence / Profile preview

Claudin-14 (CLDN14)

Target
CLDN14
Molecular classification
Tight junction protein, Other (Integral membrane protein, Claudin family)
01

Overview

Claudin-14 (CLDN14) is an integral membrane protein and a key component of tight junctions in epithelial and endothelial cells[1][2][4]. Tight junctions form a seal between adjacent cells and restrict the free passage of solutes and water through the paracellular space. Claudin-14 is especially important in the kidney, where it regulates calcium reabsorption by controlling the permeability of the thick ascending limb of the loop of Henle[2][3]. It physically interacts with other claudins (notably CLDN16 and CLDN19), modulating cation selectivity and transport[3]. In the inner ear, CLDN14 maintains proper ion gradients critical for hearing; loss-of-function mutations cause a form of autosomal recessive nonsyndromic sensorineural deafness (DFNB29)[1][2][4]. Genetic variants in the CLDN14 gene are strongly associated with kidney stone formation and altered bone mineral density[2][3][4]. There is emerging evidence that dysregulation of CLDN14 may contribute to tumor angiogenesis and other pathologies, but its role as a direct drug target remains under investigation[1][2]. No drugs are currently known to directly target CLDN14.

Other names
Claudin-14CLDN14UNQ777/PRO1571DFNB29
02

Biological functions

Maintains tight junction integrityRegulates paracellular ion permeabilityControls calcium homeostasis in kidney and cochleaParticipates in cell–cell adhesion
03

Disease associations

Nonsyndromic autosomal recessive sensorineural deafnessKidney stone (nephrolithiasis) riskBone mineral density regulationPotential role in tumor angiogenesis and cancer
04

Safety considerations

No direct safety concerns, but modulation may impact kidney function and hearing
05

Biomarkers

Mutational analysis for hereditary deafness (DFNB29)Genetic polymorphisms for kidney stone risk

Beyond the preview

Go deeper on Claudin-14 (CLDN14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Claudin-14 (CLDN14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call